Biontech Se earnings were -$870.5M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest BNTX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$452.0M, down 267.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BNTX reported annual earnings of -$693.0M, with -167% growth.
On BNTX's earnings call on Invalid Date, Biontech Se (NASDAQ: BNTX) reported Q1 2025 earnings per share (EPS) of -$1.88, up 32.02% year over year. Total BNTX earnings for the quarter were -$451.96 million. In the same quarter last year, Biontech Se's earnings per share (EPS) was -$1.42.
As of the last Biontech Se earnings report, Biontech Se is currently losing money. Biontech Se's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$832.61 million, a 777.88% decrease year over year.
What was BNTX's earnings growth in the past year?
As of Biontech Se's earnings date in Invalid Date, Biontech Se's earnings has grown year over year. BNTX earnings in the past year totalled -$870.45 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.